acapella® choice
Vibratory PEP Therapy System
Maximising therapy effectiveness, empowering patient compliance
What is oscillatory positive expiratory pressure (PEP) therapy?
Oscillatory, or vibratory, positive expiratory pressure therapy, is an airway clearance technique combining positive expiratory pressure (PEP) therapy and vibratory therapy.1
PEP therapy
Equalises bronchiole and alveolar pressure to prevent airway collapse and keep airways open2
Recruits alveoli through collateral ventilation - moving air behind trapped secretions, improving gas exchange and reversing atelectasis3,4
Vibratory therapy
Uses airflow vibrations to gently shake airway structures, loosening excess secretions and decreasing their viscosity5
OPEP therapy:6
- is effective for patients with retained or excessive secretions
- assists in clearing excess secretions from lung and airway structures
- enables patients with compromised pulmonary capacity to breathe easier
The acapella choice system allows patients to carry out OPEP therapy in their homes, without the need for assistance7
Read more →Discover the acapella choice Vibratory PEP Therapy System
Find out more about the acapella choice system →
Find out who the acapella choice system is for →
Find out about the efficacy of the acapella choice system →
Find out how the acapella choice system can benefit the NHS →References
- Cystic Fibrosis UK. Physiotherapy treatment in cystic fibrosis: airway clearance techniques. Available at: cysticfibrosis.org.uk. Accessed January 2020
- Oberwaldner B, Evans J C, Zach M S. Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatr Pulmonol 1986;2(6):358-367
- Andersen J B, Qvist J, Kann T. Recruiting collapsed lung through collateral channels with positive end-expiratory pressure. Scand J Respir Dis 1979;60(5):260-266
- Groth S, Stafanger G et al. Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol Respir 1985;21(4):339-343
- Bronchiectasis Toolbox. Oscillating positive expiratory pressure therapy. Available at: bronchiectasis.com.au. Accessed January 2020
- Burudpakdee C, Seetasith A et al. A real-world study of 30-day exacerbation outcomes in chronic obstructive pulmonary disease (COPD) patients managed with Aerobika OPEP. Pulmonary Therapy 2017;3:163-171
- acapella choice blue human factors engineering final report
Smiths Medical is part of the global technology business Smiths Group plc. Product(s) described may not be licensed or available for sale in all countries. BCI, CADD, Deltec, Graseby, Jelco, Level 1, Medex, Medfusion, Pneupac, Portex, Surgivet, Smiths Medical and all corresponding design marks are trademarks of Smiths Medical. The symbol ® indicates the trademark is registered in the U.S. Patent and Trademark Office and certain other countries. All other names and marks mentioned are the trade names, trademarks or service marks of their respective owners. Please see the Instructions for Use for a complete listing of the indications, contraindications, warnings and precautions.